Search Results: Professional 156-587 Examinations Actual Questions - Easy and Guaranteed 156-587 Exam Success ☘ Easily obtain ⮆ 156-587 ⮄ for free download through ⇛ www.pdfvce.com ⇚ 💺156-587 Latest Exam Question
After the Compliance Date: Revised Common Rule FAQs (Or: Why We Cancelled Our February Webinar)
We have cancelled our webinar “After the Compliance Date: Revised Common Rule FAQs,” which was originally scheduled for February 28.
Beginner’s Guide to Minimal Risk Research
How can researchers know when research is minimal risk? Learn an overview and the regulatory flexibilities that might be eligible.
Navigating the FDA Emergency Use Filing Process
Partnering with Advarra, one nonprofit successfully obtained an Emergency Use Authorization from the FDA within five weeks.
Institutional Review Board Services
Solutions to safeguard trial participants regardless of project scope, therapeutic niche, or number of investigators.
James Riddle and Luke Gelinas Explore Digital Health and Regulation
This podcast covers an array of topics as they explore how COVID has been a catalyst for change, what digital health means for running clinical trials, and how sponsors, CROs, sites, and IRBs can consider when reviewing new digital technologies as a result of COVID.
All Services
See how we advance clinical research by enabling the research ecosystem to develop life changing therapies
Diving into Single IRB Implementation
In this episode, we get an inside look at how institutions implement sIRB requirements and how to overcome potential challenges.
Decentralized Clinical Trials and Regulatory Changes
We discuss the evolution of decentralized trial modalities and possible solutions to regulatory challenges.
Integration Update: Expanded FAQ for Advarra Merger Efforts
The following FAQ expands upon previous FAQs we’ve published and provides additional insight into the integration process.
My Favorite Case Study: Patient Centricity in Research
We discuss patient-centric strategies at CSL Behring to improve the patient experience and retention in clinical trials.